Immunome, Inc.
665 Stockton Drive, Suite 300
Exton, PA 19341
September 29, 2020
Via Edgar
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn: Ms. Tracie Mariner
Mr. Al Pavot
Ms. Julia Griffith
Mr. Dietrich King
RE: | Immunome, Inc. Registration Statement on Form S-1 File No. 333-248687 |
Acceleration Request
Requested Date: Thursday, October 1, 2020
Requested Time: 4:00 p.m. Eastern Time
Ladies and Gentlemen:
In accordance with Rule 461 under the Securities Act of 1933, as amended, Immunome, Inc. (the “Registrant”) hereby requests that the U.S. Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-1 (File No. 333-248687) to become effective on Thursday, October 1, 2020, at 4:00 p.m., Eastern Time, or as soon thereafter as is practicable or at such later time as the Registrant’s counsel may orally request via telephone call to the staff of the Commission. The Registrant hereby authorizes each of Jeffrey Libson and Brandon Fenn of Cooley LLP, counsel to the Registrant, to make such request on its behalf.
Once the Registration Statement has been declared effective, please orally confirm that event with Jeffrey Libson of Cooley LLP, counsel to the Registrant, at (609) 250-6302, or in his absence, Brandon Fenn at (212) 479-6626.
[Signature Page Follows]
Very truly yours, | ||
Immunome, Inc. | ||
By: | /s/ Purnanand D. Sarma | |
Name: | Purnanand D. Sarma | |
Title: | President and Chief Executive Officer |
cc: | Jeffrey P. Libson, Cooley LLP |
Ryan S. Sansom, Cooley LLP
Geoffrey R. Starr, Cooley LLP
Brandon Fenn, Cooley LLP
Michael D. Maline, Goodwin Procter LLP
Michael J. Rosenberg, Goodwin Procter LLP